MedTrace Logo

Postbiotic MBS and Metformin Combination in Patients With T2DM

NCT04639492 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2023-01-05

No results posted yet for this study

Summary

The primary objective is to evaluate the effect of MBS treatment in human subjects, and to validate its impact on intestinal flora and diabetes symptoms on diabetic patients undertaking metformin. The scientific data collected will be referenced for future product development.

Conditions

  • Type-II Diabetes

Interventions

DIETARY_SUPPLEMENT

MBS oral solution

Oral BIDAC, twice a day before breakfast and dinner times

Sponsors & Collaborators

  • Microbio Co Ltd

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-02
Primary Completion
2022-06-30
Completion
2022-09-23

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04639492 on ClinicalTrials.gov